Current update on the treatment of genital warts

Valerie R. Yanofsky, Rita V. Linkner, David Pompei, Gary Goldenberg

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

External genital warts (EGW) are currently the most common form of viral sexually transmitted disease found in the general population. EGW have been shown to occur as a direct result of infection with the human papillomavirus (HPV). Malignancy is typically associated with high-risk types of HPV; however, low-risk type association has been observed. Numerous therapies are presently indicated for use in the treatment of EGW, which can target lesions through multiple modalities including topically, surgically or via immune modulation. Therapies often differ dramatically with respect to cost, side-effect profiles, dosing schedules, duration of treatment and overall effectiveness. Routine HPV vaccination may play a powerful role in reducing the burden of disease by preventing viral infection and transmission. As HPV vaccination continues to gain widespread approval, it may prove instrumental in decreasing the incidence of HPV infection and eventually eradicating genital warts.

Original languageEnglish
Pages (from-to)321-332
Number of pages12
JournalExpert Review of Dermatology
Volume8
Issue number3
DOIs
StatePublished - Jun 2013

Keywords

  • HPV vaccination
  • condyloma acuminata
  • external genital warts
  • human papillomavirus
  • imiquimod cream
  • sinecatechins ointment
  • verrucous carcinoma

Fingerprint

Dive into the research topics of 'Current update on the treatment of genital warts'. Together they form a unique fingerprint.

Cite this